Crossmark

Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study

Crossref DOI link: https://doi.org/10.1007/s00198-015-3415-4

Published Online: 2015-11-17

Published Print: 2016-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Brozek, W.

Reichardt, B.

Zwerina, J.

Dimai, H. P.

Klaushofer, K.

Zwettler, E.
License Information

Text and Data Mining valid from 2015-11-17